Clout Bio Innovators Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -96.84%
(FY 2023)
- Profit -52495.89%
(FY 2023)
- Ebitda -5114.98%
(FY 2023)
- Net Worth -1399.17%
(FY 2023)
- Total Assets 141.41%
(FY 2023)
About Clout Bio Innovators
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajith Gopalakrishnan and Mahesh Krishna serve as directors at the Company.
- CIN/LLPIN
U74990KL2018PTC054226
- Company No.
054226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Clout Bio Innovators?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Krishna  | Director | 03-Aug-2018 | Current |
| Ajith Gopalakrishnan | Director | 03-Aug-2018 | Current |
Financial Performance of Clout Bio Innovators.
Clout Bio Innovators Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.84% decrease. The company also saw a substantial fall in profitability, with a 52495.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1399.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clout Bio Innovators?
Unlock access to Clout Bio Innovators's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Carmic Tech Solutions Private LimitedActive 5 years 5 monthsAjith Gopalakrishnan is a mutual person
- Integrated Order Automated Solutions Private LimitedActive 6 years 3 months
Ajith Gopalakrishnan is a mutual person
- Tech Quest Innovations Private LimitedActive 5 years 5 months
Ajith Gopalakrishnan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clout Bio Innovators?
Unlock and access historical data on people associated with Clout Bio Innovators, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clout Bio Innovators, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clout Bio Innovators's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
